Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 7 (July)

1. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
   J Clin Oncol, 25(19): 2819-24. [Abstract] [Full-text]
2. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
   Int J Cancer, 121(4): 825-31. [Abstract] [Full-text]
3. Cutaneous lymphomas.
   J Dtsch Dermatol Ges, 5(7): 605-17. [Abstract] [Full-text]
4. Detection of papillomaviral sequences in feline Bowenoid in situ carcinoma using consensus primers.
   Vet Dermatol, 18(4): 241-5. [Abstract] [Full-text]
5. Lentigo maligna of the eyelid a rare finding in African Americans.
   Ophthalmology, 114(7): 1409-12. [Abstract] [Full-text]
6. A 3' enhancer controls snail expression in melanoma cells.
   Cancer Res, 67(13): 6113-20. [Abstract] [Full-text]
7. Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis.
   Cancer Res, 67(13): 6106-12. [Abstract] [Full-text]
8. Cerebral myiasis associated with angiosarcoma of the scalp: case report.
   Neurosurgery, 61(1): E167; discussion E167. [Abstract] [Full-text]
9. Bovine papillomavirus load and mRNA expression, cell proliferation and p53 expression in four clinical types of equine sarcoid.
   J Gen Virol, 88: 2155-61. [Abstract] [Full-text]
10. Association of methylenetetrahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients.
    Transplantation, 84(1): 113-6. [Abstract] [Full-text]
11. The power and limitations of pharmacogenetic epidemiology.
    J Invest Dermatol, 127(8): 1851-2. [Abstract] [Full-text]
12. Giant congenital melanocytic nevi.
    Plast Reconstr Surg, 120(2): 26e-40e. [Abstract] [Full-text]
13. Gene-drug interaction at the glucocorticoid receptor increases risk of squamous cell skin cancer.
    J Invest Dermatol, 127(8): 1868-70. [Abstract] [Full-text]
14. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
    Mutat Res, 632(1): 104-10. [Abstract] [Full-text]
15. Multiple polypoid basal cell carcinomas on the perineum of a patient with basal cell nevus syndrome.
    J Am Acad Dermatol, 57(2): S36-7. [Abstract] [Full-text]
16. Solar elastosis in cutaneous melanoma.
    Am J Clin Pathol, 128(2): 260-4. [Abstract] [Full-text]
17. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
    J Clin Oncol, 25(21): 3109-15. [Abstract] [Full-text]
18. The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice.
    Radiat Res, 168(2): 218-25. [Abstract] [Full-text]
19. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
    Radiology, 244(2): 566-74. [Abstract] [Full-text]
20. Occupation and keratinocyte cancer risk: a population-based case-control study.
    Cancer Causes Control, 18(8): 895-908. [Abstract] [Full-text]
21. Correlation of embryonic fusion planes with the anatomical distribution of basal cell carcinoma.
    Dermatol Surg, 33(8): 957-64; discussion 965. [Abstract] [Full-text]
22. Metastatic cutaneous squamous cell carcinoma: an update.
    Dermatol Surg, 33(8): 885-99. [Abstract] [Full-text]
23. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG).
    J Dtsch Dermatol Ges, 5(8): 662-8. [Abstract] [Full-text]
24. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients.
    Cancer Immunol Immunother, 56(10): 1667-76. [Abstract] [Full-text]
25. A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes.
    Cancer Immunol Immunother, 56(10): 1565-75. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.